W Fleischhacker-Wolfgang
Innsbruck, 6020, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The use of long-acting injectables in early-phase schizophrenia - Authors' reply.
Journal: The lancet. Psychiatry
Published: April 15, 2023
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST).
Journal: The lancet. Psychiatry
Published: August 19, 2022
The usefulness of rating scales in patients with schizophrenia.
Journal: Acta psychiatrica Scandinavica
Published: May 14, 2016
Antipsychotic-induced tardive syndromes
Journal: Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater
Published: March 07, 2016
Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
Journal: Schizophrenia research
Published: September 28, 2015
Authors' reply.
Journal: The British journal of psychiatry : the journal of mental science
Published: February 04, 2015
Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: December 23, 2014
Effects of aripiprazole once-monthly on domains of personal and social performance: results from 2 multicenter, randomized, double-blind studies.
Journal: Schizophrenia research
Published: July 09, 2014
New therapeutic approaches for treatment-resistant schizophrenia: a look to the future.
Journal: Journal of psychiatric research
Published: April 14, 2014
Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial.
Journal: The Journal of clinical psychiatry
Published: May 02, 2013
Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia.
Journal: International clinical psychopharmacology
Published: April 26, 2013
Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
Journal: The international journal of neuropsychopharmacology
Published: December 21, 2012
Last Updated: 09/26/2026